Search Results - dengue

3 Results Sort By:
COMPOSITIONS AND METHODS FOR TREATING RNA VIRUS INFECTION
COMPOSITIONS AND METHODS FOR TREATING RNA VIRUS INFECTION Researchers at Stanford have developed a method of treating or preventing an infection from an RNA virus. Viral pathogens are an ongoing threat to public health worldwide. Upon infection, RNA viruses must remodel host machinery to promote viral protein production while also suppressing host...
Published: 5/11/2022   |   Inventor(s): Raul Andino, Judith Frydman
Keywords(s): Biomolecules, Dengue, Dengue Virus, Flavivirus, Proteostasis, Ribosomes
Category(s): Technology Classifications > Biology
BROADLY NEUTRALIZING ANTIBODIES AGAINST DENGUE VIRUS
BROADLY NEUTRALIZING ANTIBODIES AGAINST DENGUE VIRUS Researchers at Stanford and the Chan Zuckerberg Biohub have discovered cross reactive, broadly neutralizing human antibodies against all serotypes of dengue virus. Dengue virus (DENV) is transmitted to humans through mosquitos and causes approximately 400 million global infections each year. DENV...
Published: 12/14/2020   |   Inventor(s): Fabio Zanini, Derek Croote, Makeda Robinson, Leslie Goo, Stephen Quake, Shirit Einav, Krista McCutcheon
Keywords(s): Broadly Neutralizing Antibodies (bNAbs), Dengue, Flavivirus, Monoclonal Antibodies (mAbs), Single-cell Transcriptomics, Vaccine
Category(s): Technology Classifications > Biology
AFUCOSYLATED MATERNAL ANTI-DENGUE IGGS ARE A BIOMARKER FOR SUSCEPTIBILITY TO SEVERE DENGUE DISEASE IN INFANTS
AFUCOSYLATED MATERNAL ANTI-DENGUE IGGS ARE A BIOMARKER FOR SUSCEPTIBILITY TO SEVERE DENGUE DISEASE IN INFANTS Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed a method for determining infant susceptibility to severe dengue disease through measurement of maternal anti-dengue IgG. Mortality rates in severe dengue...
Published: 11/9/2020   |   Inventor(s): Taia Wang
Keywords(s): Afucosylation, Antibody, Dengue, Fc Domain, Glycosylation, IgG
Category(s): Technology Classifications > Biology